Tuesday, November 17, 2020 2:03:23 PM
SAFETY & EFFICACY ARE WHAT MATTERS
Once the shift towards therapeutics being the answer is fully recognized, the promising ones will skyrocket. This has not happened yet but will soon. Big Pharma is eyeing up acquisitions already, ones with proven safety and efficacy will rise to the top.
RVVTF has this, just like the other company RLFTF. Both actually have a 30 year track record as well. I think it is entirely possible they could be used in conjunction at some point. Look at the MOA of bucillamine and do your DD.
That being said, only "traders" are releasing shares. As an investor, I will hang onto my RVVTF position as I see good things coming.
I pick winners...
Best,
JB
Once the shift towards therapeutics being the answer is fully recognized, the promising ones will skyrocket. This has not happened yet but will soon. Big Pharma is eyeing up acquisitions already, ones with proven safety and efficacy will rise to the top.
RVVTF has this, just like the other company RLFTF. Both actually have a 30 year track record as well. I think it is entirely possible they could be used in conjunction at some point. Look at the MOA of bucillamine and do your DD.
That being said, only "traders" are releasing shares. As an investor, I will hang onto my RVVTF position as I see good things coming.
I pick winners...
Best,
JB
Disclaimer
All of my posts are just my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. I post my own personal thoughts and information that I have found regarding positions that I am invested in.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
